Get More Information on Respiratory Devices Market- Request Sample Report
The Respiratory Devices Market Size was valued at USD 22.62 billion in 2023 and is projected to reach USD 46.10 billion by 2032, growing at a robust CAGR of 8.27 % during the forecast period of 2024-2032.
Respiratory devices are essential in helping with breathing by providing oxygen and maintaining proper airflow into the lungs at different pressures. The increasing prevalence of respiratory diseases like (Chronic Obstructive Pulmonary Disease) COPD, asthma, and sleep apnea is greatly fueling the need for these devices. Around 936 million American adults suffer from sleep apnea, creating a large demand for respiratory devices as per the National Council on Aging. The high occurrence of respiratory illnesses requires regular hospital and clinic visits, leading to a higher demand for effective diagnosis and treatment options. This increasing necessity results in an increased requirement for advanced respiratory equipment that can provide efficient treatment for these conditions. The market was significantly affected by the COVID-19 pandemic, with a rise in the need for ventilators, masks, and other respiratory devices as a result of the increased number of patients experiencing respiratory problems related to the virus. This resulted in an increase in the availability and dissemination of respiratory devices, boosting the income of healthcare providers and having a positive impact on the market. An important driver of market growth is the emphasis placed by top manufacturers on developing creative and effective respiratory solutions through technological advancements. For example, the market is projected to expand more due to developments in device technology and a growing focus on respiratory health.
Significant growth and adoption in the respiratory device market are being driven by profound technological advancements. Recent advancements have led to the creation of smaller and more portable oxygen concentrators, improving the ability of patients in need of long-term oxygen therapy to move around easily and conveniently. CPAP machines have been upgraded to include built-in sensors and data analysis capabilities that enhance treatment by automatically adjusting pressure levels according to the patient's breathing patterns. Moreover, improvements in nebulizer technology have resulted in more effective and user-friendly devices, featuring enhanced aerosol delivery systems that enhance the effectiveness of medication. These advancements in technology improve patient comfort and device effectiveness, as well as increase the use of respiratory devices in homes and medical facilities. Approximately 16 million Americans have been diagnosed with COPD, highlighting the importance of advanced respiratory solutions, as stated by the U.S. National Institutes of Health (NIH). Likewise, the World Health Organization (WHO) emphasizes the crucial importance of sophisticated respiratory equipment in treating chronic respiratory illnesses (WHO Respiratory Disease Statistics). Therefore, it is anticipated that the respiratory devices market will maintain its strong growth due to technological advancements meeting the changing demands of patients and healthcare professionals.
Drivers
Increasing occurrence of respiratory conditions drives need for advanced respiratory equipment.
The increasing occurrence of respiratory disorders like sleep apnea, COPD, and asthma is a major factor fueling the growth of the worldwide market for respiratory devices. With the rise in prevalence of these conditions, there has been a growing need for diagnosis and treatment options, prompting a greater dependence on respiratory devices in different healthcare environments. Based on a report from NHLBI in 2023, around 16 million American adults have COPD, highlighting the increasing demand for better management and treatment choices. This rise in respiratory illnesses is not just increasing the number of diagnoses but also prompting healthcare organizations to put in place strategic efforts to promote awareness of respiratory health. These efforts, along with an increased emphasis on detecting and treating illnesses early, are leading to a greater need for cutting-edge respiratory equipment. The increased need for advanced devices has led respiratory equipment companies to concentrate on creating and launching innovative products that meet the changing requirements of patients and healthcare providers. An example would be the noticeable rise in the creation of portable and easy-to-use equipment, like compact oxygen concentrators and advanced CPAP machines that improve patient comfort and treatment effectiveness. Additionally, the growing healthcare infrastructure in developing countries such as China and India is predicted to help boost the use of these advanced respiratory devices. These nations are experiencing a rise in healthcare funding, which is enabling the incorporation of state-of-the-art respiratory technologies into their healthcare systems. Consequently, the respiratory devices market is set to experience significant growth in the foreseeable future, propelled by the combination of rising disease rates, technological progress, and healthcare infrastructure expansion. There is a predicted increase in focus on respiratory health and ongoing advancements in device technology.
Increasing Respiratory Conditions Leading to Growth in the Worldwide Respiratory Equipment Industry
The respiratory devices market is growing substantially due to the increasing prevalence of respiratory disorders globally. Long-term diseases like Chronic Obstructive Pulmonary Disease (COPD) and asthma have become significant health problems, impacting millions of people in developed and developing areas. COPD has seen a significant increase in becoming a top cause of death worldwide, as emphasized by the World Health Organization (WHO). As per a WHO document published in March 2023, more than 200 million individuals are affected by COPD, leading to 3.23 million fatalities in just 2019, with 65 million people having moderate-to-severe variations of the condition. The increasing occurrence of respiratory diseases is strongly connected to various factors, such as rising air pollution, a growing elderly population, and changes in lifestyle like smoking and less physical activity. Additionally, sleep-disordered breathing impacts about 1-6% of adult’s worldwide, totaling more than 100 million individuals, highlighting the importance of reliable respiratory treatment. The increase in respiratory illnesses is driving the need for innovative treatments and diagnostic methods, establishing the respiratory devices market as an essential part of worldwide healthcare systems. The urgent requirement to control and reduce the impact of respiratory illnesses has pushed device producers to broaden their range of products, providing creative solutions like advanced ventilators, portable oxygen concentrators, and state-of-the-art Continuous Positive Airway Pressure (CPAP) devices. These improvements are not just improving patient results but are also addressing the increasing need from healthcare providers managing a larger population of respiratory patients. Therefore, the worldwide respiratory devices market will keep growing due to the rising number of respiratory disorders and the need for advanced medical technologies to treat this pressing issue.
Restraints
Shortage of skilled labor in developing markets presents a hurdle to the growth of the respiratory devices market.
The increasing presence of respiratory illnesses like COPD and asthma is boosting the worldwide respiratory devices market, but it is hindered by a shortage of qualified workers in developing nations. As respiratory disorders become more common, the need for diagnosis and treatment is increasing, but there is a lack of qualified respiratory therapists causing a bottleneck in healthcare services. In 2022, the British Thoracic Society revealed that the United Kingdom had a deficit of respiratory therapists, with only around 4,000 professionals available to address the increasing demands of patients with respiratory illnesses. This lack is even more noticeable in developing countries, where the healthcare system is still growing and there is a more severe shortage of trained professionals. The inadequate number of skilled respiratory therapists is a barrier to accurately diagnosing and treating respiratory conditions, resulting in a greater burden of disease and unaddressed patient needs. Furthermore, the scarcity of professionals significantly influences the uptake and use of respiratory devices. Lack of proper clinical guidance and support can lead to lower adherence to prescribed treatments, worsening the problem. A recent 2022 study released by the National Center for Biotechnology Information (NCBI) revealed that the adherence rates for treatments of obstructive pulmonary disease vary from 10% to 40%, indicating a notable disparity in patient adherence. This lack of compliance, combined with the insufficient number of experienced respiratory professionals, is projected to hinder the expansion of the respiratory devices market, especially in areas where healthcare resources are already overstretched. Addressing the workforce shortages and improving patient adherence will be essential in sustaining the market's growth amid increasing demand for respiratory care. Without these essential actions, the opportunity for market expansion could be hindered, even though.
By Type
Based on Type, Therapeutic Devices capturing the largest share revenue in Respiratory Devices with 40% of share in 2023. This control is due to major technological improvements in different airway tools, like airway clearance devices, which are becoming more popular and accepted by patients. The increased emphasis on research and development by key industry players is boosting the market presence of therapeutic devices, resulting in the introduction of innovative respiratory therapy devices like ventilators and inhalers. In January 2023, Getinge AB launched the Servo-c ventilator, created for adult and pediatric patients with respiratory diseases, intending to broaden its range of ICU products. Innovations play a crucial role in fueling the growth of the sector by meeting the changing needs of patients and healthcare providers. Furthermore, there will be significant growth in the diagnostic and monitoring devices segment, fueled by the rising rates of diagnosis for respiratory conditions such as COPD and asthma. This trend is resulting in an increased need for diagnostic devices, as companies are concentrating on mergers, partnerships, and developing new products to enhance their market position. Likewise, there is an expected growth in the consumables and accessories sector, driven by key players taking strategic actions to increase awareness of respiratory devices. The demand for necessary items like masks, nasal cannulas, and other accessories is increasing as a result. Businesses are more frequently introducing new products and organizing information drives to boost the usage of these devices among patients, additionally fueling the overall expansion of the respiratory devices industry. Collaborative work in innovation, product development, and strategic partnerships is essential for sustaining the market's growth in these areas.
By End User
Based on End User, Hospitals and ASCs is capturing the largest share revenue in Respiratory Devices market with 39% of share in 2023. The increasing patient admissions for treating sleep apnea, asthma, and other respiratory disorders are the main reason for this dominance in these settings. The rising occurrence of respiratory disorders, along with the increasing amount of hospitals and ASCs, is a major factor in driving the growth of this sector. An instance is when, as per data released by above & beyond Therapy in 2023, there are a total of 7,335 operational hospitals in the United States, showcasing the vast resources allocated for respiratory treatment. The growth of hospitals and ASC facilities is increasing the need for respiratory devices and prompting manufacturers to develop innovative solutions specific to these settings. Businesses are more and more creating specialized respiratory solutions for use in hospitals and clinical settings. Companies such as Philips and ResMed are always coming up with new ideas for their CPAP machines and ventilators, which are designed to meet the needs of both hospitalized and non-hospitalized patients. Furthermore, the specialty clinics sector is expected to experience significant expansion, particularly in developing countries like Brazil, China, and India, as the quantity of specialty clinics is increasing. These clinics are seeing more patients with respiratory disorders, resulting in an increase in both inpatient and outpatient admissions. At the same time, the home care settings sector should also see an increase, fueled by the release of items such as Cipla's Spirofy, a portable spirometer with wireless capabilities launched in November 2021. These advancements are simplifying the way patients can control their respiratory issues at home, which is also broadening the market for respiratory devices. As the need for respiratory products for home care increases, it will likely contribute to the increasing use of these devices, along with the strong growth seen in hospitals and clinics.
Need any customization research on Respiratory Devices market - Enquiry Now
North America dominate the Respiratory Devices market with 36% of share in 2023. Fueled by various factors such as the increasing need for therapeutic and diagnostic & monitoring equipment, a strong lineup of leading companies pursuing regulatory clearances, and strategic efforts to raise awareness of advanced respiratory technologies. Healthcare organizations in the area are actively promoting the advantages of modern respiratory devices, which reinforces the region's leading position. In November 2023, Vivos Therapeutics was granted U.S. FDA approval for its Vivos CARE oral appliance aimed at addressing obstructive sleep apnea, highlighting the area's emphasis on innovation and regulatory progress. Having major players like Philips Respironics and ResMed in North America also helps in maintaining the region's dominance in the market. These companies lead in creating innovative solutions like advanced CPAP machines and portable ventilators for the rising need for respiratory care at home and in clinical settings.
The Asia-Pacific region is also expected to experience considerable growth in the respiratory devices market in the coming years. This growth will be driven by the increasing number of elderly individuals who are at higher risk of respiratory issues like asthma and infectious diseases. The growth in the region is especially significant in nations such as China and India, where the increasing number of elderly people is boosting the need for advanced respiratory devices. The Government of China's 2023 data show around 297 million individuals aged 60 and older, a group that is increasingly in need of respiratory support. The increasing need is pushing major players to prioritize mergers, acquisitions, and partnerships to enhance their market influence in the area. For instance, Fisher & Paykel Healthcare and Air Liquide are increasing their presence in Asia Pacific in order to take advantage of the growing market. These companies are launching new, cutting-edge products like sophisticated humidifiers and respiratory masks designed specifically for the elderly population.
The Major Players are Koninklijke Philips N.V., Medtronic, ResMed Inc., Fisher & Paykel Healthcare Limited, Masimo, Getinge AG, GE HealthCare, Baxter, OMRON Corporation, Xplore Health Technologies Pvt. Ltd. & Others Players
In May 2024, Medline Industries, Inc. released Hudson RCI TurboMist, a compact nebulizer designed for administering medication to patients, in order to enhance its range of products.
In March 2024, Berry Global introduced the BerryHaler, a dry powder inhaler with a dose counter, designed to facilitate the efficient administration of combination medications to patients.
In November 2023, GE Healthcare and Masimo partnered to introduce SET pulse oximetry on the portrait mobile platform of the wireless and wearable company, enhancing its worldwide reach.
In September 2022, Onera Health introduced a service for polysomnography to diagnose sleep disorders in patients, with the goal of expanding its footprint in Germany and the Netherlands.
In May 2022, Max Ventilator introduced versatile Non-Invasive (NIV) ventilators with integrated oxygen therapy to satisfy the increasing patient needs.
| Report Attributes | Details |
| Market Size in 2023 | USD 22.62 Billion |
| Market Size by 2032 | USD 46.10 Billion |
| CAGR | CAGR of 8.27 % From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Type (Therapeutic Devices [Positive Airway Pressure (PAP) Devices, Airway Management Devices, Ventilators, Inhalers, Nebulizers, Others], Diagnostic & Monitoring Devices [Spirometers, Polysomnography Devices, Pulse Oximeters and Others], and Consumables and Accessories [Masks, Nasal Cannula and Others]) • By Application (Chronic Obstructive Pulmonary Disease (COPD), Sleep Apnea, Asthma, Infectious Diseases, and Others) • By End-User (Hospitals & ASCs, Specialty Clinics, Home Care Settings, and Others) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia-Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles |
Koninklijke Philips N.V., Medtronic, ResMed, Inc., Fisher & Paykel Healthcare Limited, Masimo, Getinge AG, GE HealthCare, Baxter, OMRON Corporation, Xplore Health Technologies Pvt. Ltd. & Others |
| Key Drivers | • Increasing occurrence of respiratory conditions drives need for advanced respiratory equipment. • Increasing Respiratory Conditions Leading to Growth in the Worldwide Respiratory Equipment Industry |
| RESTRAINTS | • Shortage of skilled labor in developing markets presents a hurdle to the growth of the respiratory devices market. |
Ans: The Respiratory Devices Market is expected to grow at a CAGR of 8.27 % during 2024-2032.
Ans: The Respiratory Devices Market was valued at USD 22.62 billion in 2023 and is projected to reach USD 46.10 billion by 2032, growing at a robust CAGR of 8.27 % during the forecast period of 2024-2032.
Ans: The major growth factor of the Respiratory Devices Market is the increasing prevalence of respiratory diseases, such as COPD and asthma, coupled with technological advancements in respiratory care devices.
Ans: The Therapeutic Devices segment dominated the Respiratory Devices Market.
Ans: North America dominated the Respiratory Devices Market in 2023.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence (2023)
5.2 Prescription Trends, (2023), by Region
5.3 Device Volume, by Region (2020-2032)
5.4 Healthcare Spending, by Region, (Government, Commercial, Private, Out-of-Pocket), 2023
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and supply chain strategies
6.4.3 Expansion plans and new product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Respiratory Devices Market Segmentation, by Type
7.1 Chapter Overview
7.2 Positive Airway Pressure (PAP) Devices
7.2.1 Positive Airway Pressure (PAP) Devices Market Trends Analysis (2020-2032)
7.2.2 Positive Airway Pressure (PAP) Devices Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.1 Airway Management Devices
7.2.1.1 Airway Management Devices Market Trends Analysis (2020-2032)
7.2.1.2 Airway Management Devices Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.2 Ventilators
7.2.2.1 Ventilators Market Trends Analysis (2020-2032)
7.2.2.2 Ventilators Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.3 Inhalers
7.2.3.1 Inhalers Market Trends Analysis (2020-2032)
7.2.3.2 Inhalers Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.4 Nebulizers
7.2.4.1 Nebulizers Market Trends Analysis (2020-2032)
7.2.4.2 Nebulizers Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.5 Others
7.2.5.1Others Market Trends Analysis (2020-2032)
7.2.5.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Diagnostic & Monitoring Devices
7.3.1 Diagnostic & Monitoring Devices Market Trends Analysis (2020-2032)
7.3.2 Diagnostic & Monitoring Devices Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.1 Spirometers
7.3.1 Spirometers Market Trends Analysis (2020-2032)
7.3.2 Spirometers Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.2 Polysomnography Devices
7.3.2.1 Polysomnography Devices Market Trends Analysis (2020-2032)
7.3.2.2 Polysomnography Devices Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.3 Pulse Oximeters
7.3.3.1 Pulse Oximeters Market Trends Analysis (2020-2032)
7.3.3.2 Pulse Oximeters Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.3 Others
7.3.3.1 Others Market Trends Analysis (2020-2032)
7.3.3.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Consumables and Accessories
7.4.1 Consumables and Accessories Market Trends Analysis (2020-2032)
7.4.2 Consumables and Accessories Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4.1 Masks
7.4.1.1Masks Market Trends Analysis (2020-2032)
7.4.1.2 Masks Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4.2 Nasal Cannula
7.4.2.1 Nasal Cannula Market Trends Analysis (2020-2032)
7.4.2.2 Nasal Cannula Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4.3 Others
7.4.3.1 Others Market Trends Analysis (2020-2032)
7.4.3.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Respiratory Devices Market Segmentation, by Application
8.1 Chapter Overview
8.2 Chronic Obstructive Pulmonary Disease (COPD)
8.2.1 Chronic Obstructive Pulmonary Disease (COPD) Market Trends Analysis (2020-2032)
8.2.2 Chronic Obstructive Pulmonary Disease (COPD) Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Sleep Apnea
8.3.1 Sleep Apnea Market Trends Analysis (2020-2032)
8.3.2 Sleep Apnea Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Asthma
8.4.1 Asthma Market Trends Analysis (2020-2032)
8.4.2 Asthma Market Size Estimates and Forecasts to 2032 (USD Billion)
8.5 Infectious Diseases
8.5.1 Infectious Diseases Market Trends Analysis (2020-2032)
8.5.2 Infectious Diseases Market Size Estimates and Forecasts to 2032 (USD Billion)
8.6 Others
8.6.1 Others Market Trends Analysis (2020-2032)
8.6.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Respiratory Devices Market Segmentation, by End User
9.1 Chapter Overview
9.2 Hospitals and ASCs
9.2.1 Hospitals and ASCs Market Trends Analysis (2020-2032)
9.2.2 Hospitals and ASCs Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3 Specialty Clinics
9.3.1 Specialty Clinics Market Trends Analysis (2020-2032)
9.3.2 Specialty Clinics Market Size Estimates and Forecasts to 2032 (USD Billion)
9.4 Home Care Settings
9.4.1 Home Care Settings Market Trends Analysis (2020-2032)
9.4.2 Home Care Settings Market Size Estimates and Forecasts to 2032 (USD Billion)
9.5 Others
9.5.1 Others Market Trends Analysis (2020-2032)
9.5.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
10. Regional Analysis
10.1 Chapter Overview
10.2 North America
10.2.1 Trends Analysis
10.2.2 North America Respiratory Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.2.3 North America Respiratory Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.2.4 North America Respiratory Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.5 North America Respiratory Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.2.6 USA
10.2.6.1 USA Respiratory Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.2.6.2 USA Respiratory Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.6.3 USA Respiratory Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.2.7 Canada
10.2.7.1 Canada Respiratory Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.2.7.2 Canada Respiratory Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.7.3 Canada Respiratory Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.2.8 Mexico
10.2.8.1 Mexico Respiratory Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.2.8.2 Mexico Respiratory Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.8.3 Mexico Respiratory Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3 Europe
10.3.1 Eastern Europe
10.3.1.1 Trends Analysis
10.3.1.2 Eastern Europe Respiratory Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.1.3 Eastern Europe Respiratory Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.4 Eastern Europe Respiratory Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.5 Eastern Europe Respiratory Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.1.6 Poland
10.3.1.6.1 Poland Respiratory Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.6.2 Poland Respiratory Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.6.3 Poland Respiratory Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.1.7 Romania
10.3.1.7.1 Romania Respiratory Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.7.2 Romania Respiratory Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.7.3 Romania Respiratory Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.1.8 Hungary
10.3.1.8.1 Hungary Respiratory Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.8.2 Hungary Respiratory Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.8.3 Hungary Respiratory Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.1.9 Turkey
10.3.1.9.1 Turkey Respiratory Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.9.2 Turkey Respiratory Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.9.3 Turkey Respiratory Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.1.10 Rest of Eastern Europe
10.3.1.10.1 Rest of Eastern Europe Respiratory Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.10.2 Rest of Eastern Europe Respiratory Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.10.3 Rest of Eastern Europe Respiratory Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2 Western Europe
10.3.2.1 Trends Analysis
10.3.2.2 Western Europe Respiratory Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.2.3 Western Europe Respiratory Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.4 Western Europe Respiratory Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.5 Western Europe Respiratory Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.6 Germany
10.3.2.6.1 Germany Respiratory Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.6.2 Germany Respiratory Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.6.3 Germany Respiratory Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.7 France
10.3.2.7.1 France Respiratory Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.7.2 France Respiratory Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.7.3 France Respiratory Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.8 UK
10.3.2.8.1 UK Respiratory Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.8.2 UK Respiratory Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.8.3 UK Respiratory Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.9 Italy
10.3.2.9.1 Italy Respiratory Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.9.2 Italy Respiratory Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.9.3 Italy Respiratory Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.10 Spain
10.3.2.10.1 Spain Respiratory Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.10.2 Spain Respiratory Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.10.3 Spain Respiratory Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.11 Netherlands
10.3.2.11.1 Netherlands Respiratory Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.11.2 Netherlands Respiratory Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.11.3 Netherlands Respiratory Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.12 Switzerland
10.3.2.12.1 Switzerland Respiratory Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.12.2 Switzerland Respiratory Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.12.3 Switzerland Respiratory Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.13 Austria
10.3.2.13.1 Austria Respiratory Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.13.2 Austria Respiratory Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.13.3 Austria Respiratory Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.14 Rest of Western Europe
10.3.2.14.1 Rest of Western Europe Respiratory Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.14.2 Rest of Western Europe Respiratory Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.14.3 Rest of Western Europe Respiratory Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4 Asia-Pacific
10.4.1 Trends Analysis
10.4.2 Asia Pacific Respiratory Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.4.3 Asia Pacific Respiratory Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.4 Asia Pacific Respiratory Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.5 Asia Pacific Respiratory Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.6 China
10.4.6.1 China Respiratory Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.6.2 China Respiratory Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.6.3 China Respiratory Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.7 India
10.4.7.1 India Respiratory Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.7.2 India Respiratory Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.7.3 India Respiratory Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.8 Japan
10.4.8.1 Japan Respiratory Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.8.2 Japan Respiratory Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.8.3 Japan Respiratory Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.9 South Korea
10.4.9.1 South Korea Respiratory Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.9.2 South Korea Respiratory Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.9.3 South Korea Respiratory Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.10 Vietnam
10.4.10.1 Vietnam Respiratory Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.10.2 Vietnam Respiratory Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.10.3 Vietnam Respiratory Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.11 Singapore
10.4.11.1 Singapore Respiratory Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.11.2 Singapore Respiratory Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.11.3 Singapore Respiratory Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.12 Australia
10.4.12.1 Australia Respiratory Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.12.2 Australia Respiratory Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.12.3 Australia Respiratory Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.13 Rest of Asia Pacific
10.4.13.1 Rest of Asia Pacific Respiratory Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.13.2 Rest of Asia Pacific Respiratory Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.13.3 Rest of Asia Pacific Respiratory Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5 Middle East and Africa
10.5.1 Middle East
10.5.1.1 Trends Analysis
10.5.1.2 Middle East Respiratory Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.1.3 Middle East Respiratory Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.4 Middle East Respiratory Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.5 Middle East Respiratory Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.1.6 UAE
10.5.1.6.1 UAE Respiratory Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.6.2 UAE Respiratory Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.6.3 UAE Respiratory Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.1.7 Egypt
10.5.1.7.1 Egypt Respiratory Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.7.2 Egypt Respiratory Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.7.3 Egypt Respiratory Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.1.8 Saudi Arabia
10.5.1.8.1 Saudi Arabia Respiratory Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.8.2 Saudi Arabia Respiratory Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.8.3 Saudi Arabia Respiratory Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.1.9 Qatar
10.5.1.9.1 Qatar Respiratory Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.9.2 Qatar Respiratory Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.9.3 Qatar Respiratory Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.1.10 Rest of Middle East
10.5.1.10.1 Rest of Middle East Respiratory Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.10.2 Rest of Middle East Respiratory Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.10.3 Rest of Middle East Respiratory Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.2 Africa
10.5.2.1 Trends Analysis
10.5.2.2 Africa Respiratory Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.2.3 Africa Respiratory Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.2.4 Africa Respiratory Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.5 Africa Respiratory Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.2.6 South Africa
10.5.2.6.1 South Africa Respiratory Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.2.6.2 South Africa Respiratory Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.6.3 South Africa Respiratory Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.2.7 Nigeria
10.5.2.7.1 Nigeria Respiratory Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.2.7.2 Nigeria Respiratory Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.7.3 Nigeria Respiratory Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.2.8 Rest of Africa
10.5.2.8.1 Rest of Africa Respiratory Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.2.8.2 Rest of Africa Respiratory Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.8.3 Rest of Africa Respiratory Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.6 Latin America
10.6.1 Trends Analysis
10.6.2 Latin America Respiratory Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.6.3 Latin America Respiratory Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.4 Latin America Respiratory Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.5 Latin America Respiratory Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.6.6 Brazil
10.6.6.1 Brazil Respiratory Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.6.2 Brazil Respiratory Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.6.3 Brazil Respiratory Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.6.7 Argentina
10.6.7.1 Argentina Respiratory Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.7.2 Argentina Respiratory Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.7.3 Argentina Respiratory Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.6.8 Colombia
10.6.8.1 Colombia Respiratory Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.8.2 Colombia Respiratory Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.8.3 Colombia Respiratory Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.6.9 Rest of Latin America
10.6.9.1 Rest of Latin America Respiratory Devices Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.9.2 Rest of Latin America Respiratory Devices Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.9.3 Rest of Latin America Respiratory Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11. Company Profiles
11.1 Koninklijke Philips N.V.
11.1.1 Company Overview
11.1.2 Financial
11.1.3 Products/ Services Offered
11.1.4 SWOT Analysis
11.2 Medtronic
11.2.1 Company Overview
11.2.2 Financial
11.2.3 Products/ Services Offered
11.2.4 SWOT Analysis
11.3 ResMed, Inc.
11.3.1 Company Overview
11.3.2 Financial
11.3.3 Products/ Services Offered
11.3.4 SWOT Analysis
11.4 Fisher & Paykel Healthcare Limited
11.4.1 Company Overview
11.4.2 Financial
11.4.3 Products/ Services Offered
11.4.4 SWOT Analysis
11.5 Masimo
11.5.1 Company Overview
11.5.2 Financial
11.5.3 Products/ Services Offered
11.5.4 SWOT Analysis
11.6 Getinge AG
11.6.1 Company Overview
11.6.2 Financial
11.6.3 Products/ Services Offered
11.6.4 SWOT Analysis
11.7 GE HealthCare
11.7.1 Company Overview
11.7.2 Financial
11.7.3 Products/ Services Offered
11.7.4 SWOT Analysis
11.8 Baxter
11.8.1 Company Overview
11.8.2 Financial
11.8.3 Products/ Services Offered
11.8.4 SWOT Analysis
11.9 OMRON Corporation
11.9.1 Company Overview
11.9.2 Financial
11.9.3 Products/ Services Offered
11.9.4 SWOT Analysis
11.10 Xplore Health Technologies Pvt. Ltd.
11.10.1 Company Overview
11.10.2 Financial
11.10.3 Products/ Services Offered
11.10.4 SWOT Analysis
12. Use Cases and Best Practices
13. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
By Type
Therapeutic Devices
Positive Airway Pressure (PAP) Devices
Airway Management Devices
Ventilators
Inhalers
Nebulizers
Others
Diagnostic & Monitoring Devices
Spirometers
Polysomnography Devices
Pulse Oximeters
Others
Consumables and Accessories
Masks
Nasal Cannula
Others
By Application
Chronic Obstructive Pulmonary Disease (COPD)
Sleep Apnea
Asthma
Infectious Diseases
Others
By End-User
Hospitals and ASCs
Specialty Clinics
Home Care Settings
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
REGIONAL COVERAGE:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia-Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of the Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Product Matrix which gives a detailed comparison of the product portfolio of each company
Geographic Analysis
Additional countries in any of the regions
Company Information
Detailed analysis and profiling of additional market players (Up to five)
The Internet of Things in Healthcare Market Size was valued at USD 121.20 billion in 2023, and is expected to reach USD 471.20 billion by 2031 and grow at a CAGR of 21.4% over the forecast period 2024-2031.
The Predictive Genetic Testing & Consumer/Wellness Genomics Market Size was valued at USD 2.2 billion in 2023, and is expected to reach USD 5.10 billion by 2031, and grow at a CAGR of 11.1% over the forecast period 2024-2031.
The Diabetic Ulcer Treatment Market Size was valued at USD 4.12 billion in 2023, and is expected to reach USD 8.65 billion by 2032, and grow at a CAGR of 8.60% over the forecast period 2024-2032.
The Healthcare Interoperability Solutions Market Size was valued at USD 3.4 billion in 2023 and is expected to reach USD 10.9 billion by 2032 and grow at a CAGR of 13.8% over the forecast period 2024-2032.
The Clinical Trial Management System Market Size was valued at USD 1.82 billion in 2023, and is expected to reach USD 5.49 billion by 2031 and grow at a CAGR of 14.8% over the forecast period 2024-2031.
The Nano Biotechnology Market Size was valued at USD 5.6 billion in 2023, and is expected to reach USD 12.67 billion by 2031 and grow at a CAGR of 9.5% over the forecast period 2024-2031.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
